These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2441694)

  • 1. The structure of hepatitis B surface antigen and its antigenic sites.
    Peterson DL
    Bioessays; 1987 Jun; 6(6):258-62. PubMed ID: 2441694
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant.
    Chen WN; Oon CJ; Toh I
    Am J Gastroenterol; 2000 Apr; 95(4):1098-9. PubMed ID: 10763979
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV variants and hepatitis B surface antigen mutants.
    Zuckerman AJ
    J Med Virol; 2006; 78 Suppl 1():S1-2. PubMed ID: 16622868
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
    Tan GH; Yusoff K; Seow HF; Tan WS
    J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants.
    Chong-Jin O; Wei Ning C; Shiuan K; Gek Keow L
    J Infect Dis; 1999 Jan; 179(1):259-63. PubMed ID: 9841851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change.
    Ren F; Tsubota A; Hirokawa T; Kumada H; Yang Z; Tanaka H
    Gene; 2006 Nov; 383():43-51. PubMed ID: 16963200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
    Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
    Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
    Jeantet D; Chemin I; Mandrand B; Zoulim F; Trepo C; Kay A
    Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen.
    Chi SW; Kim DH; Kim JS; Lee MK; Han KH
    Antiviral Res; 2006 Dec; 72(3):207-15. PubMed ID: 16872688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prokaryocytic expression of the shortened hepatitis B surface antigen and antigenic analysis].
    Ling N; Ren H; Peng ML; Xu HM; Qing YL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):209-11. PubMed ID: 12716516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin.
    Torresi J
    Antivir Ther; 2008; 13(3):337-40. PubMed ID: 18572745
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of the minor i and t determinants of hepatitis B virus in hepatocellular carcinoma.
    Zhao Y; Oon CJ; Lim GK
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1237-40. PubMed ID: 9918432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel target of hepatitis B virus mutations: splicing of surface RNA.
    Baumert TF; Köck J; Blum HE
    Hepatology; 2005 Jul; 42(1):21-3. PubMed ID: 15962324
    [No Abstract]   [Full Text] [Related]  

  • 19. A new hepatitis B virus vaccine escape mutation in a renal transplant recipient.
    Sayiner AA; Agca H; Sengonul A; Celik A; Akarsu M
    J Clin Virol; 2007 Feb; 38(2):157-60. PubMed ID: 17210268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.